What makes a good drug target?

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Drug Discovery Today

• Publication date

  2011-12-01

• Fields of study

  Medicine, Business

• Identifiers
  DOI 10.1016/j.drudis.2011.09.007PMID 21945861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current prospects for RNA interference-based therapies

  2011cited by this paper
• Proteomic biomarkers for diagnosis in acute myocardial infarction

  2011cited by this paper
• Trends in the exploitation of novel drug targets

  2011cited by this paper
• Trial watch: Phase II failures: 2008–2010

  2011cited by this paper
• Inhibition of the IL‐2‐inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases

  2011cited by this paper
• Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer

  2011cited by this paper
• High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells

  2011cited by this paper
• Pharma interest surges in antibody drug conjugates

  2011cited by this paper
• Grants4Targets - an innovative approach to translate ideas from basic research into novel drugs.

  2011cited by this paper
• Crowd sourcing in drug discovery

  2011cited by this paper
• Biomarkers for intensive care medicine patients: the (stony) path into a bright future?

  2011cited by this paper
• Trial watch: Phase III and submission failures: 2007–2010

  2011cited by this paper
• Believe it or not: how much can we rely on published data on potential drug targets?

  2011cited by this paper
• The year's new drugs & biologics, 2010.

  2011cited by this paper
• The translatability of animal models for clinical development: biomarkers and disease models.

  2010cited by this paper
• Animalgesic effects

  2010cited by this paper
• Antibody–drug conjugates for cancer: poised to deliver?

  2010cited by this paper
• The lack of target specificity of small molecule anticancer kinase inhibitors is correlated with their ability to damage myocytes in vitro.

  2010cited by this paper
• DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs

  2010cited by this paper
• Phenoclustering: online mining of cross-species phenotypes

  2010cited by this paper
• Suppression of inflammation by a synthetic histone mimic

  2010cited by this paper
• Turning enzymes ON with small molecules.

  2010cited by this paper
• Selective inhibition of BET bromodomains

  2010cited by this paper
• Lessons from 60 years of pharmaceutical innovation

  2009cited by this paper
• Update of TTD: Therapeutic Target Database

  2009cited by this paper
• Direct inhibition of the NOTCH transcription factor complex

  2009cited by this paper
• Properties and identification of human protein drug targets

  2009cited by this paper
• Inhibiting the teratogenicity of the immunosuppressant leflunomide in mice by supplementation of exogenous uridine.

  2009cited by this paper
• Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling.

  2009cited by this paper
• Computational approaches to identifying and characterizing protein binding sites for ligand design

  2009cited by this paper
• Exome sequencing identifies the cause of a Mendelian disorder

  2009cited by this paper
• Ariadne: a database search engine for identification and chemical analysis of RNA using tandem mass spectrometry data

  2009cited by this paper
• Systemic first-line phenotyping.

  2009cited by this paper
• Triumph of the Heart: The Story of Statins

  2009cited by this paper
• Mining phenotypes for gene function prediction

  2008cited by this paper
• A structural biology view of target drugability

  2008cited by this paper
• Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation

  2008cited by this paper
• Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins.

  2008cited by this paper
• Safety and anti-tumor activity of sorafenib (Nexavar®) in combination with other anti-cancer agents: a review of clinical trials

  2008cited by this paper
• Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

  2008cited by this paper
• Network pharmacology: the next paradigm in drug discovery.

  2008cited by this paper
• PDTD: a web-accessible protein database for drug target identification

  2008cited by this paper
• Drugs, their targets and the nature and number of drug targets

  2007cited by this paper
• Pathway mapping tools for analysis of high content data.

  2007cited by this paper
• Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

  2007cited by this paper
• How many drug targets are there?

  2006cited by this paper
• Analytical platforms for activity-based protein profiling--exploiting the versatility of chemistry for functional proteomics.

  2006cited by this paper
• Drugs, their targets and the nature and number of drug targets

  2006cited by this paper
• The anti-intellectual effects of intellectual property.

  2006cited by this paper
• The Target Discovery Process

  2005cited by this paper
• Omic space: coordinate-based integration and analysis of genomic phenomic interactions

  2004cited by this paper
• Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

  2003cited by this paper
• The year's new drugs.

  1998cited by this paper
• Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.

  1993cited by this paper
• University of Birmingham

  1951cited by this paper

• OriGene: A Self-Evolving Virtual Disease Biologist Automating Therapeutic Target Discovery

  2026cites this paper
• GEMap: A comprehensive gene essentiality map for drug discovery

  2026cites this paper
• Potential next generation targets for antibacterial agent's discovery and development.

  2025cites this paper
• Incorporation of target safety review in drug discovery.

  2025cites this paper
• A map of molecular drug targets and therapeutics for the US FDA-approved drugs: The impact of expedited regulatory pathways and first-in-class drug approvals on drug innovation.

  2025cites this paper
• Advancing Target Validation and Ligandability Assessment: Fragment Screening via 19F NMR Spectroscopy.

  2025cites this paper
• Daclatasvir, a symmetric drug for an anti-symmetric target

  2025cites this paper
• On the potential value of eHTA: a commentary on “Defining Early Health Technology Assessment: Building Consensus Using Delphi Technique”

  2025cites this paper
• Artificial Intelligence in Small-Molecule Drug Discovery: A Critical Review of Methods, Applications, and Real-World Outcomes

  2025cites this paper
• Structural and Kinetic Profiling of Leishmania braziliensis Trypanothione Reductase: A Molecular Model for the Development of Targeted Therapies.

  2025cites this paper
• Antiviral drug repurposing: different approaches and the case of antifungal drugs.

  2025cites this paper
• BENDER DB: a database of protein binding sites across neglected disease proteomes

  2025cites this paper
• Novel drug targets for the early treatment of acute pancreatitis: Focusing on calcium signaling.

  2025cites this paper
• Efficient Deep Model Ensemble Framework for Drug-Target Interaction Prediction.

  2024cites this paper
• Comprehensive applications of the artificial intelligence technology in new drug research and development

  2024cites this paper
• Computer-Aided Drug Discovery and Design: Recent Advances and Future Prospects.

  2024cites this paper
• Efficient and knowledge-based hierarchal virtual screening applied to identify potential inhibitors of cholinesterase enzyme

  2024cites this paper
• Drug-target Affinity Prediction by Molecule Secondary Structure Representation Network.

  2024cites this paper
• Development of Oxadiazolone Activity-Based Probes Targeting FphE for Specific Detection of Staphylococcus aureus Infections.

  2024cites this paper
• Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system

  2024cites this paper
• Biochemical and cellular characterization of the CISD3 protein: Molecular bases of cluster release and destabilizing effects of nitric oxide

  2024cites this paper
• Revolutionizing Neurosurgery and Neurology: The transformative impact of artificial intelligence in healthcare

  2024influential citation
• Screening of drug targets for tuberculosis on the basis of transcription factor regulatory network and mRNA sequencing technology

  2024cites this paper
• The Gene Expression Landscape of Disease Genes

  2024cites this paper
• Druggability Analysis of Protein Targets for Drug Discovery to Combat Listeria monocytogenes

  2024influential citation
• Immunohistochemical detection of cancer genetic abnormalities.

  2024cites this paper
• Identification of plasma protein markers of allergic disease risk: a mendelian randomization approach to proteomic analysis

  2024cites this paper
• Immunological drivers and potential novel drug targets for major psychiatric, neurodevelopmental, and neurodegenerative conditions

  2024cites this paper
• The Art of Finding the Right Drug Target: Emerging Methods and Strategies

  2024cites this paper
• Similarity of drug targets to human microbiome metaproteome promotes pharmacological promiscuity

  2024cites this paper
• Antifungal Compound from the Predatory Bacterium Lysobacter enzymogenes Inhibits a Plant Pathogenic Fungus by Targeting the AAA ATPase VpVeb1.

  2023cites this paper
• Screening and Biological Evaluation of Soluble Epoxide Hydrolase Inhibitors: Assessing the Role of Hydrophobicity in the Pharmacophore-Guided Search of Novel Hits

  2023cites this paper
• Drug discovery and development: introduction to the general public and patient groups

  2023cites this paper
• Bivalent Transition Metal Complexes of O and N Donor Schiff Base Ligand: Synthesis, Cyclic Voltammetry Studies and Molecular Docking Approach Compatible with Promising Biological Studies

  2023cites this paper
• Robust and Adaptive Deep Model Ensemble Framework Fine-tuned by Structural Information for Drug-Target Interactions

  2023cites this paper
• Proteome-wide Mendelian Randomization Analysis Identified Potential Drug Targets for Myocardial Infarction

  2023cites this paper
• Unlocking the Potential of Kinase Targets in Cancer: Insights from CancerOmicsNet, an AI-Driven Approach to Drug Response Prediction in Cancer

  2023cites this paper
• The Impact of Computational Drug Discovery on Society

  2023cites this paper
• Screening of trypsin inhibitors in Cotinus coggygria Scop. extract using at-line nanofractionation coupled with semi-preparative reverse-phase liquid chromatography.

  2023cites this paper
• Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression

  2023cites this paper
• Quantum chemical computations on molecular composition, spectroscopic properties, topology exploration, NLO, ligand protein interactions and pharmacokinetic evaluation of 8-hydroxyquinolium 3-nitrobenzoate

  2023cites this paper
• Proteome‐Wide Mendelian Randomization Analysis Identified Potential Drug Targets for Atrial Fibrillation

  2023cites this paper
• Development of Oxadiazolone Activity-Based Probes Targeting FphE for Specific Detection of S. aureus Infections

  2023cites this paper
• Combination therapy: synergism among three plant extracts against selected pathogens

  2023cites this paper
• Role of Syndecans in Ovarian Cancer: New Diagnostic and Prognostic Biomarkers and Potential Therapeutic Targets

  2023cites this paper
• Differential Expression of the β3 Subunit of Voltage-Gated Ca2+ Channel in Mesial Temporal Lobe Epilepsy

  2023cites this paper
• Frameworks for Health Technology Assessment at an Early Stage of Product Development: A Review and Roadmap to Guide Applications.

  2023cites this paper
• A Systematic Review on Clinical Research and Approval Process

  2023cites this paper
• Innate functions of natural products: A promising path for the identification of novel therapeutics.

  2023cites this paper
• Chip-DSF: A rapid screening strategy for drug protein targets.

  2022cites this paper
• Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies

  2022cites this paper
• Measurement and valuation of the attributes of innovation of healthcare technologies: a systematic review

  2022cites this paper
• Tumor-Promoting ATAD2 and Its Preclinical Challenges

  2022cites this paper
• Identification and Prioritization of PET Neuroimaging Targets for Microglial Phenotypes Associated with Microglial Activity in Alzheimer's Disease.

  2022cites this paper
• Non-swarm-based computational approach for mining cancer drug target modules in protein interaction network

  2022cites this paper
• Characterizing attributes of innovation of technologies for healthcare: a systematic review

  2022cites this paper
• Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years

  2022cites this paper
• Indonesian Journal of Pharmacology and Therapy

  2022cites this paper
• Label-free target protein characterization for small molecule drugs: recent advances in methods and applications.

  2022cites this paper
• Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?

  2022cites this paper
• Redefining genomic view of Clostridioides difficile through pangenome analysis and identification of drug targets from its core genome

  2022cites this paper
• Zebrafish Is a Powerful Tool for Precision Medicine Approaches to Neurological Disorders

  2022cites this paper
• Application of Whole Genome Sequencing in Medical and Pharmaceutical field

  2022cites this paper
• Evaluation of Drug Repositioning by Molecular Docking of Pharmaceutical Resources to Identification of Potential SARS-CoV-2 Viral Inhibitors

  2022cites this paper
• Research progress of single-cell transcriptome sequencing in autoimmune diseases and autoinflammatory disease: A review.

  2022cites this paper
• TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer

  2022cites this paper
• QuoteTarget: A sequence‐based transformer protein language model to identify potentially druggable protein targets

  2022cites this paper
• Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease

  2022cites this paper
• Targeting platelet inhibition receptors for novel therapies: PECAM-1 and G6b-B

  2021cites this paper
• A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine

  2021cites this paper
• SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development

  2021cites this paper
• Recent advances in stem cells and gene editing: Drug discovery and therapeutics.

  2021cites this paper
• Contemporary Molecular Analyses of Malignant Tumors for Precision Treatment and the Implication in Oral Squamous Cell Carcinoma

  2021influential citation
• Drug design, discovery and development and their safety or efficacy on human body

  2021cites this paper
• High-Throughput Screening Reveals New Glutaminase Inhibitor Molecules.

  2021cites this paper
• Modulating undruggable targets to overcome cancer therapy resistance.

  2021cites this paper
• Logic-Based Modeling and Virtual Drug Screening for the Prediction of Novel Therapeutic Targets and Combination Regimens Against E2F1-driven Melanoma Progression

  2021cites this paper
• Rediscovering and repurposing natural microbial macromolecules through computational approaches

  2021cites this paper
• New Bioinformatics Platform‐Based Approach for Drug Design

  2021cites this paper
• Prioritization of Molecular Targets for Antimalarial Drug Discovery

  2021cites this paper
• Mapping genetic determinants of 184 circulating proteins in 26,494 individuals to connect proteins and disease.

  2021cites this paper
• Approaches for network based drug discovery.

  2021cites this paper
• Introduction to drug discovery

  2021cites this paper
• Target identification and validation

  2021cites this paper
• From Genome to Drugs: New Approaches in Antimicrobial Discovery

  2021cites this paper
• Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer’s Disease and Related Dementias

  2021cites this paper
• Target identification and validation

  2021cites this paper
• Prospect into therapeutic potentials of Moringa oleifera phytocompounds against cancer upsurge: de novo synthesis of test compounds, molecular docking, and ADMET studies

  2021cites this paper
• Drug Target Identification and Validation

  2021cites this paper
• Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

  2020cites this paper
• Developing Novel Anticancer Drugs for Targeted Populations: An Update.

  2020cites this paper
• Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets

  2020cites this paper
• Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections

  2020cites this paper
• Chimeric poly(N-isopropylacrylamide)-b-poly(3,4-dihydroxy-L-phenylalanine) nanocarriers for temperature/pH dual-stimuli-responsive theranostic application

  2020cites this paper
• The Journey of Human Drugs from Their Design at the Bench to Their Fate in Crops

  2020cites this paper
• Improving target assessment in biomedical research: the GOT-IT recommendations

  2020cites this paper
• Computational Approaches for Drug Target Identification

  2020cites this paper
• Network Insights into Improving Drug Target Inference Algorithms

  2020cites this paper
• The strategies and techniques of drug discovery from natural products.

  2020cites this paper
• Handling the Hurdles on the Way to Anti-tuberculosis Drug Development

  2020cites this paper